Pall and New Brunswick Collaborate on Single-Use Bioreactors

Article

New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.

New Brunswick Scientific, an Eppendorf Company (Edison, NJ), and Pall Corporation (Port Washington, NY) have entered into a product development and marketing agreement to create and supply new disposable bioreactor systems.
The joint effort will build on the capabilities of Pall's Allegro single-use biocontainer platform and New Brunswick's CelliGen bioprocess controller to better serve upstream applications ranging from the process development laboratory to the full-scale cGMP production suite.

Recent Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Related Content
© 2025 MJH Life Sciences

All rights reserved.